COVID-19 Pandemic: A Pragmatic plan for Therapeutic Intervention

Author:

Bhattacharjee Atanu1,Randhoni Chanu Nongmaithem2,Bhattacharya Kunal3

Affiliation:

1. Royal School of Pharmacy, Royal Global University, Guwahati, Assam – 781035.

2. Faculty of Pharmaceutical Science, Assam Downtown University, Assam – 781026.

3. NETES Institute of Pharmaceutical Science, Mirza, Kamrup, Assam – 781125.

Abstract

The prevalence of the Novel Coronavirus Covid-19 pandemic is growing worldwide and the third phase of this deadly flu has already been started across the globe. COVID-19 has already been emerged as one of the most devastating epidemics throughout the world with the highest rate of mortality and has become the most important health challenge in developed and developing countries. This paper totals and solidifies the study of disease transmission, clinical signs, finding, medications and counteractions of this new sort of COVID-19. Data were collected from the articles published in various electronic databases such as Elsevier, Science Direct, Scopus, PubMed between 2010 and 2020. Existing literature, news and media, a various statutory body of the Health Ministry of various countries, World Health Organization (WHO) has said that there is no particular medicine to prevent or treat coronavirus disease till date. Few antiviral drugs combination of lopinavir and ritonavir, antimalarial drugs like chloroquine and hydroxychloroquine are widely used as an effective medicine to treat COVID-19 to date. A search vaccine is in progress up to the clinical trial stage in many countries including China, the USA and India. Need of the hour is high-quality clinical data from different geographic areas to develop the vaccine and safe drugs.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3